Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736560) titled 'Effects of Antimuscarinic Drugs on Ejaculation Duration and Refractory Period in Men With Overactive Bladder' on July 26.
Study Type: Observational
Primary Sponsor: Basaksehir Çam & Sakura City Hospital
Condition:
Overactive Bladder (OAB)
Premature (Early) Ejaculation
Ejaculation Abnormal
Intervention:
Drug: Tolterodine
Drug: Propiverine tablet
Recruitment Status: Not recruiting
Date of First Enrollment: January 15, 2026
Target Sample Size: 60
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07736560
Disclaimer: Curated by HT Syndication....